Dianthus Therapeutics, Inc. (DNTH) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - DNTH

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth-67.35%

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth102.86%

5Y CAGR-11.84%

10Y CAGRN/A

Equity

1Y Growth39.98%

5Y CAGR27.95%

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	-67.3%	-15.1%	-31.8%	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	120.6%	-1.4%	61.7%	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	-56.0%	38.4%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	334.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2017 Dec 31, 2017	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2016 Dec 31, 2016	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - DNTH

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Dianthus Therapeutics, Inc.

Compare with peers

Explore

Growth Analysis - DNTH

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Dianthus Therapeutics, Inc.

Compare with peers

Explore